-
18911-1A DCA trimer that is at least 10-fold more cytotoxic against leukemia cell lines than DCA significantly reduces both basal and maximal respiration in leukemia cells.
-
18911-10A DCA trimer that is at least 10-fold more cytotoxic against leukemia cell lines than DCA significantly reduces both basal and maximal respiration in leukemia cells.
-
18911-25A DCA trimer that is at least 10-fold more cytotoxic against leukemia cell lines than DCA significantly reduces both basal and maximal respiration in leukemia cells.
-
18911-5A DCA trimer that is at least 10-fold more cytotoxic against leukemia cell lines than DCA significantly reduces both basal and maximal respiration in leukemia cells.
-
19240-1A potent inhibitor of HCV infection (EC<sub>50</sub> = 17 nM) that displays low cytotoxicity of virally-infected human hepatoma Huh7.5.
-
19240-10A potent inhibitor of HCV infection (EC<sub>50</sub> = 17 nM) that displays low cytotoxicity of virally-infected human hepatoma Huh7.5.
-
19240-5A potent inhibitor of HCV infection (EC<sub>50</sub> = 17 nM) that displays low cytotoxicity of virally-infected human hepatoma Huh7.5.
-
19473-1A substituted diamine that produces rapid bactericidal activity against both Gram-positive and Gram-negative bacteria displays MIC99 values of 2.9, 11.
-
19473-10A substituted diamine that produces rapid bactericidal activity against both Gram-positive and Gram-negative bacteria displays MIC99 values of 2.9, 11.
-
19473-25A substituted diamine that produces rapid bactericidal activity against both Gram-positive and Gram-negative bacteria displays MIC99 values of 2.9, 11.
-
19473-5A substituted diamine that produces rapid bactericidal activity against both Gram-positive and Gram-negative bacteria displays MIC99 values of 2.9, 11.
-
20469-1A selective inhibitor of the breast cancer resistance protein ABCG2 (IC<sub>50</sub> = 0.23 µM).